These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1853957)

  • 1. Fluoxetine in the treatment of borderline and schizotypal personality disorders.
    Markovitz PJ; Calabrese JR; Schulz SC; Meltzer HY
    Am J Psychiatry; 1991 Aug; 148(8):1064-7. PubMed ID: 1853957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo.
    Goldberg SC; Schulz SC; Schulz PM; Resnick RJ; Hamer RM; Friedel RO
    Arch Gen Psychiatry; 1986 Jul; 43(7):680-6. PubMed ID: 3521531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tranquilizers on borderline and schizotypal patients questioned.
    Rockland LH
    Am J Psychiatry; 1985 May; 142(5):665-6. PubMed ID: 3885764
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluoxetine in borderline personality disorder.
    Norden MJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(6):885-93. PubMed ID: 2813806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary trial of fluoxetine in refractory borderline patients.
    Cornelius JR; Soloff PH; Perel JM; Ulrich RF
    J Clin Psychopharmacol; 1991 Apr; 11(2):116-20. PubMed ID: 2056138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol.
    Serban G; Siegel S
    Am J Psychiatry; 1984 Nov; 141(11):1455-8. PubMed ID: 6388363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome of psychopharmacologic treatment of borderline and schizotypal personality disordered subjects.
    Coccaro EF
    J Clin Psychiatry; 1998; 59 Suppl 1():30-5; discussion 36-7. PubMed ID: 9448667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open trial of valproate in borderline personality disorder.
    Stein DJ; Simeon D; Frenkel M; Islam MN; Hollander E
    J Clin Psychiatry; 1995 Nov; 56(11):506-10. PubMed ID: 7592502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine trial in borderline personality disorder.
    Cornelius JR; Soloff PH; Perel JM; Ulrich RF
    Psychopharmacol Bull; 1990; 26(1):151-4. PubMed ID: 2371370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy for patients with borderline personality disorder.
    Gunderson JG
    Arch Gen Psychiatry; 1986 Jul; 43(7):698-700. PubMed ID: 2872871
    [No Abstract]   [Full Text] [Related]  

  • 11. Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder.
    Chengappa KN; Ebeling T; Kang JS; Levine J; Parepally H
    J Clin Psychiatry; 1999 Jul; 60(7):477-84. PubMed ID: 10453803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open, noncomparative study of amoxapine in borderline disorders.
    Jensen HV; Andersen J
    Acta Psychiatr Scand; 1989 Jan; 79(1):89-93. PubMed ID: 2648768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder.
    Salzman C; Wolfson AN; Schatzberg A; Looper J; Henke R; Albanese M; Schwartz J; Miyawaki E
    J Clin Psychopharmacol; 1995 Feb; 15(1):23-9. PubMed ID: 7714224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Borderline personality disorder: symptomatology and MMPI characteristics.
    Resnick RJ; Schulz P; Schulz SC; Hamer RM; Friedel RO; Goldberg SC
    J Clin Psychiatry; 1983 Aug; 44(8):289-92. PubMed ID: 6874649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of schizotypal and borderline symptoms in parasuicide patients: comparison between subjective and objective indices.
    Markar HR; Williams JM; Wells J; Gordon L
    Psychol Med; 1991 May; 21(2):385-92. PubMed ID: 1876644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential perception of parental bonding in schizotypal and borderline personality disorder patients.
    Torgersen S; Alnaes R
    Compr Psychiatry; 1992; 33(1):34-8. PubMed ID: 1555407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some Rorschach data comparing schizophrenics with borderline and schizotypal personality disorders.
    Exner JE
    J Pers Assess; 1986; 50(3):455-71. PubMed ID: 3806345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic, developmental and personality correlates of self-mutilation in depressed patients.
    Joyce PR; McKenzie JM; Mulder RT; Luty SE; Sullivan PF; Miller AL; Kennedy MA
    Aust N Z J Psychiatry; 2006 Mar; 40(3):225-9. PubMed ID: 16476149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in pharmacotherapy of borderline disorders. A double-blind study of amitriptyline, haloperidol, and placebo.
    Soloff PH; George A; Nathan RS; Schulz PM; Ulrich RF; Perel JM
    Arch Gen Psychiatry; 1986 Jul; 43(7):691-7. PubMed ID: 3521532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine treatment of impulsive aggression in DSM-III-R personality disorder patients.
    Coccaro EF; Astill JL; Herbert JL; Schut AG
    J Clin Psychopharmacol; 1990 Oct; 10(5):373-5. PubMed ID: 2258454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.